# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0000950170-23-046883
Filing Date
2023-09-07
Accepted
2023-09-07 07:46:43
Documents
16
Period of Report
2023-09-07
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | neog-20230907.htm iXBRL | 8-K | 54354
2 | EX-99.1 | neog-ex99_1.htm | EX-99.1 | 5349
3 | GRAPHIC | neog-ex99_1s1.jpg | GRAPHIC | 315480
4 | GRAPHIC | neog-ex99_1s2.jpg | GRAPHIC | 707002
5 | GRAPHIC | neog-ex99_1s3.jpg | GRAPHIC | 297474
| Complete submission text file | 0000950170-23-046883.txt |  | 1996630

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | neog-20230907.xsd | EX-101.SCH | 2463
7 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | neog-20230907_lab.xml | EX-101.LAB | 13474
8 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | neog-20230907_pre.xml | EX-101.PRE | 9896
10 | EXTRACTED XBRL INSTANCE DOCUMENT | neog-20230907_htm.xml | XML | 4728

Mailing Address 620 LESHER PLACE LANSING MI 48912
Business Address 620 LESHER PLACE LANSING MI 48912 5173729200
NEOGEN CORP (Filer) CIK: 0000711377 (see all company filings)

EIN.: 382367843 | State of Incorp.: MI | Fiscal Year End: 0531
Type: 8-K | Act: 34 | File No.: 000-17988 | Film No.: 231240984
SIC: 2835 In Vitro & In Vivo Diagnostic Substances